Navigating the landscape of end-of-life care and access to medications like Nembutal in New South Wales, NSW, requires a careful comprehension of the complex legal system. Currently, Pentobarbital does not have a recognized place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not commonly prescribed by healthcare professionals.